Harrow Health, Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the 2019 Annual Meeting of Stockholders held on June 6, 2019, in San Diego, California. The company, Harrow Health, Inc. (HROW), is incorporated in Delaware and trades on the NASDAQ Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Of the 24,703,649 shares entitled to vote, 15,197,198 were present or represented by proxy. Four of the five proposals were approved; Proposal 3 was rejected.
- Proposal 1 (Election of Directors): Approved. All five nominees (Stephen Austin, Mark Baum, Robert Kammer, Richard Lindstrom, Anthony Principi) were elected.
- Proposal 2 (Ratification of Auditors): Approved. KMJ Corbin and Company, LLP was ratified as the independent auditor.
- Proposal 3 (Classified Board Amendment): Rejected. Stockholders did not approve the amendment to adopt a classified Board of Directors. Votes were 9,114,861 For vs. 5,842,878 Against.
- Proposal 4 (Executive Compensation Advisory Vote): Approved. Stockholders voted to approve the compensation of named executive officers.
- Proposal 5 (Frequency of Compensation Vote): Approved. Stockholders selected a one-year frequency for future advisory votes on executive compensation.
Guidance, Outlook, and Management Commentary
The Board of Directors determined that, based on the stockholder vote, the Company will hold an advisory vote on executive compensation every 1 year until the next vote on frequency, which will occur no later than the 2025 Annual Meeting. No financial guidance or risk factors were disclosed in this specific filing.
Investor Verification Checklist
- Verify the impact of the rejected Proposal 3 on the company's governance structure and potential for future shareholder activism.
- Confirm the continued engagement of KMJ Corbin and Company, LLP as the independent auditor.
- Review the proxy statement for details on the specific compensation packages approved in Proposal 4.
- Monitor future filings for any attempts to re-submit the classified board proposal.